Cargando…
Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming Agents
First introduced during the late 1800s, radiation therapy is fundamental to the treatment of cancer. In developed countries, approximately 60% of all patients receive radiation therapy (also known as the sixty percenters), which makes radioresistance in cancer an important and, to date, unsolved, cl...
Autores principales: | Oronsky, Bryan, Scicinski, Jan, Kim, Michelle M., Cabrales, Pedro, Salacz, Michael E., Carter, Corey A., Oronsky, Neil, Lybeck, Harry, Lybeck, Michelle, Larson, Christopher, Reid, Tony R., Oronsky, Arnold |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039418/ https://www.ncbi.nlm.nih.gov/pubmed/27384589 http://dx.doi.org/10.3390/biom6030032 |
Ejemplares similares
-
No patient left behind: The promise of immune priming with epigenetic agents
por: Carter, Corey A., et al.
Publicado: (2017) -
Rewriting the Epigenetic Code for Tumor Resensitization: A Review
por: Oronsky, Bryan, et al.
Publicado: (2014) -
Medical Machiavellianism: the tradeoff between benefit and harm with targeted chemotherapy
por: Oronsky, Bryan, et al.
Publicado: (2016) -
Navigating the “No Man's Land” of TKI-Failed EGFR-Mutated Non–Small Cell Lung Cancer (NSCLC): A Review
por: Oronsky, Bryan, et al.
Publicado: (2017) -
Addressing the elephant in the room, therapeutic resistance in non-small cell lung cancer, with epigenetic therapies
por: Carter, Corey A., et al.
Publicado: (2016)